- Home
- CLDX vs UPBD Comparison
CLDX vs UPBD Comparison
Compare CLDX & UPBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- UPBD
- Stock Information
- Founded
- CLDX 1983
- UPBD 1986
- Country
- CLDX United States
- UPBD United States
- Employees
- CLDX N/A
- UPBD N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- UPBD Diversified Commercial Services
- Sector
- CLDX Health Care
- UPBD Consumer Discretionary
- Exchange
- CLDX Nasdaq
- UPBD Nasdaq
- Market Cap
- CLDX 1.7B
- UPBD 1.6B
- IPO Year
- CLDX 2008
- UPBD 1995
- Fundamental
- Price
- CLDX $22.46
- UPBD $26.56
- Analyst Decision
- CLDX Buy
- UPBD Buy
- Analyst Count
- CLDX 8
- UPBD 6
- Target Price
- CLDX $61.86
- UPBD $39.17
- AVG Volume (30 Days)
- CLDX 774.1K
- UPBD 467.4K
- Earning Date
- CLDX 03-04-2025
- UPBD 02-20-2025
- Dividend Yield
- CLDX N/A
- UPBD 5.87%
- EPS Growth
- CLDX N/A
- UPBD N/A
- EPS
- CLDX N/A
- UPBD 2.21
- Revenue
- CLDX $9,976,000.00
- UPBD $4,320,564,000.00
- Revenue This Year
- CLDX N/A
- UPBD $9.86
- Revenue Next Year
- CLDX N/A
- UPBD $4.77
- P/E Ratio
- CLDX N/A
- UPBD $12.02
- Revenue Growth
- CLDX 128.55
- UPBD 8.22
- 52 Week Low
- CLDX $20.91
- UPBD $26.30
- 52 Week High
- CLDX $53.18
- UPBD $38.72
- Technical
- Relative Strength Index (RSI)
- CLDX 42.55
- UPBD 30.79
- Support Level
- CLDX $22.38
- UPBD $28.89
- Resistance Level
- CLDX $23.69
- UPBD $30.00
- Average True Range (ATR)
- CLDX 1.07
- UPBD 1.00
- MACD
- CLDX 0.03
- UPBD -0.22
- Stochastic Oscillator
- CLDX 44.67
- UPBD 6.02
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
About UPBD Upbound Group Inc.
Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has four operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.